Uploaded October 2026 | Updated November 2026, 2 hours ago
In 2026, women's health remains hugely underrepresented in deep tech and investment with just 1% of healthcare R&D going to female-specific conditions beyond oncology. Femtech is truly life-changing for half of the world's population.
This 2026 Hello Tomorrow Summit panel explores where deep tech can make the biggest impact, how R&D priorities can be rethought, and how startups and corporates can collaborate responsibly.
Speakers:
Christian Tidona - Founder & CEO, BioMed X
Karina Vazirova - CEO / Women's Health Venture Partner, FemTech Lab / Borski Fund
Nayanika Bhalla - Investment Associate, Industrifonden
Moderated by:
Amrita Jain - Investment Director, DeepBright Ventures
🔔 Subscribe for more deep tech insights!
📲 Follow us on social media:
LinkedIn: hello-tomorrow-challenge
Instagram: hellotomorrow_official
#deeptech #healthtech #womenshealth #hellotomorrow
In 2026, women's health remains hugely underrepresented in deep tech and investment with just 1% of healthcare R&D going to female-specific conditions beyond oncology. Femtech is truly life-changing for half of the world's population.
This 2026 Hello Tomorrow Summit panel explores where deep tech can make the biggest impact, how R&D priorities can be rethought, and how startups and corporates can collaborate responsibly.
Speakers:
Christian Tidona - Founder & CEO, BioMed X
Karina Vazirova - CEO / Women's Health Venture Partner, FemTech Lab / Borski Fund
Nayanika Bhalla - Investment Associate, Industrifonden
Moderated by:
Amrita Jain - Investment Director, DeepBright Ventures
🔔 Subscribe for more deep tech insights!
📲 Follow us on social media:
LinkedIn: hello-tomorrow-challenge
Instagram: hellotomorrow_official
#deeptech #healthtech #womenshealth #hellotomorrow










